Japanese pharma major Eisai Co. has made an agreement to collaborate with the Department of Medical Services (DMS), Mini...
Swiss firm Novartis has announced that it will invest in setting up a new radiopharmaceutical production base in China t...
China Volume-Based Procurement (VBP) Policy In 2018, China introduced VBP for pharmaceuticals, as an attempt to reduce ...
Asia’s life sciences industry has not been immune to the headwinds and uncertainties. For most sectors, ranging fr...
In the Asia-Pacific region, we see two key strategic trends within Policy, Access, Value, and Evidence: Continuing and ...
2023 was the year when the world finally emerged from the grips of COVID-19. The biopharma industry looked beyond the pa...
In March 2023, Pfizer announced a $43 billion merger with Seagen, one of the most substantial M&A deals in recent ti...
BeiGene, a global, science-driven biotechnology company, has announced that its anti-cancer drug zanubrutinib, a Bruton&...
Daiichi Sankyo has reached an agreement with Japan’s Ministry of Health, Labour and Welfare (MHLW) to supply the o...
Acrometa Group, an established specialist engineering service provider in the field of controlled environments serving m...
Japan-based Astellas Pharma and US-based startup Propella Therapeutics have entered into a merger agreement pursuant to ...
The upcoming 2023 PDA Asia Pacific Regulatory Conference & Sponsored Workshop is all set to kick off a transformativ...
China-based startup Eccogene has entered into an exclusive license agreement with UK-based pharmaceutical firm AstraZene...
West Pharmaceutical Services, Inc., a global leader in innovative solutions for injectable drug administration, has appo...
Daiichi Sankyo Europe GmbH, the European headquarter organisation of the Japanese pharmaceutical company Daiichi Sankyo ...
Japan-based Hisamitsu Pharmaceutical has launched the Salonpas® Diclofenac Patch 1% in Singapore. It is the first in...
Japan based Shionogi and US based Apnimed, Inc. have agreed to establish a joint venture (JV) company, Shionogi-Apnimed ...
31 biotechnology, biopharma and life science companies and educational institutions at the forefront of mRNA and next-ge...
Japan-headquartered pharmaceutical company Daiichi Sankyo's Board has passed a resolution on the basic policy for ...
US-based startup AnHeart Therapeutics has entered into an exclusive license agreement with Nippon Kayaku to market ...
Japan-based companies Sumitomo Pharma and AlphaNavi Pharma have announced that AlphaNavi has exercised its option rights...
Merck, a leading science and technology company, has announced a strategic collaboration with China-based Jiangsu Hengru...
How is Avantor strategising to strengthen supply chain resilience and competitiveness in the AMEA biomedical sphere?&nbs...
Debiopharm International SA, Yakult Honsha and Takata Pharmaceutical have agreed that Yakult Honsha will transfer ...
British pharma firm GlaxoSmithKline (GSK) and Chinese biopharmaceutical company Hansoh Pharma have entered in...
